The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Automated bone scan index as an imaging biomarker in metastatic castration resistant prostate cancer (mCRPC) patients treated with radium-223.
 
Aseem Anand
Consulting or Advisory Role - EXINI Diagnostics
 
Stephanie Daignault
No Relationships to Disclose
 
Luke T. Nordquist
No Relationships to Disclose
 
Jorge Ramos
No Relationships to Disclose
 
Rohit K. Jain
No Relationships to Disclose
 
Matthew McDonald
No Relationships to Disclose
 
Gregory Campbell
Travel, Accommodations, Expenses - Roche/Genentech
 
Saby George
Employment - Amgen (I)
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Novartis; Onclive; Pfizer; Xcenda
Research Funding - Acceleron Pharma (Inst); Agensys (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Costantine Albany
Consulting or Advisory Role - Seagen
Speakers' Bureau - Bayer
 
Evan Y. Yu
Consulting or Advisory Role - Agensys; Bayer; Dendreon; Ferring; Genentech/Roche; Janssen; Medivation; Merck; Sanofi; Seagen; Tokai Pharmaceuticals; Tolmar
Research Funding - Agensys (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech/Roche (Inst); GTx (Inst); Lilly/ImClone; Oncogenex (Inst)
Travel, Accommodations, Expenses - Exelixis; Lilly
 
Anders Bjartell
Honoraria - EXINI Diagnostics
Consulting or Advisory Role - EXINI Diagnostics
 
Ajjai Shivaram Alva
Honoraria - Eisai
Consulting or Advisory Role - Eisai
Research Funding - BIND Biosciences; Bristol-Myers Squibb; Genentech; Novartis; Oncogenex